5 Result(s)

Article

Author Correction: A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma

Lisa Kinget, Stefan Naulaerts, Jannes Govaerts, Isaure Vanmeerbeek… in Nature Medicine (2024)

Article

Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma

Malignant pleural mesothelioma (MPM) is a heterogeneous cancer. Better knowledge of molecular and cellular intra-tumor heterogeneity throughout the thoracic cavity is required to develop efficient therapies. T...

Clément Meiller, François Montagne, Theo Z. Hirsch, Stefano Caruso… in Genome Medicine (2021)

Article

The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma

Efforts have been made to classify Hepatocellular Carcinoma (HCC) at surgically curable stages because molecular classification, which is prognostically informative, can accurately identify patients in need of...

Sung-Min Ahn, Farhan Haq, Inkeun Park, Jean-Charles Nault… in BMC Cancer (2018)

Article

Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a particularly severe disease characterized by a high rate of recurrence and death even after surgical resection. Molecular characterization of HCC helps refine prognosis and ...

Adeodat Ilboudo, Jean-Charles Nault, Hélène Dubois-Pot-Schneider, Anne Corlu… in BMC Cancer (2014)

Article

HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines

Hepatocyte Nuclear Factor 1α (HNF1α) is an atypical homeodomain-containing transcription factor that transactivates liver-specific genes including albumin, α-1-antitrypsin and α- and β-fibrinogen. Biallelic in...

Laura Pelletier, Sandra Rebouissou, Danijela Vignjevic, Paulette Bioulac-Sage… in BMC Cancer (2011)